204 related articles for article (PubMed ID: 18683964)
1. Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.
Xun Z; Kaufman TC; Clemmer DE
J Proteome Res; 2008 Sep; 7(9):3911-21. PubMed ID: 18683964
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766
[TBL] [Abstract][Full Text] [Related]
3. Lifetime proteomic profiling of an A30P alpha-synuclein Drosophila model of Parkinson's disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
J Proteome Res; 2007 Sep; 6(9):3729-38. PubMed ID: 17683129
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Profiling of Synuclein Species: Application to Transgenic Mouse Models of Parkinson's Disease.
Singh S; Khayachi A; Milnerwood AJ; DeMarco ML
J Parkinsons Dis; 2020; 10(2):613-621. PubMed ID: 32083592
[TBL] [Abstract][Full Text] [Related]
5. Protein expression in a Drosophila model of Parkinson's disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
J Proteome Res; 2007 Jan; 6(1):348-57. PubMed ID: 17203978
[TBL] [Abstract][Full Text] [Related]
6. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
7. Proteomics of Caenorhabditis elegans over-expressing human alpha-synuclein analyzed by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry: identification of actin and several ribosomal proteins as negative markers at early Parkinson's disease stages.
Ichibangase T; Saimaru H; Takamura N; Kuwahara T; Koyama A; Iwatsubo T; Imai K
Biomed Chromatogr; 2008 Mar; 22(3):232-4. PubMed ID: 17939164
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.
Bhattacharjee P; Öhrfelt A; Lashley T; Blennow K; Brinkmalm A; Zetterberg H
J Proteome Res; 2019 May; 18(5):2109-2120. PubMed ID: 30943367
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies.
Shaltiel-Karyo R; Frenkel-Pinter M; Egoz-Matia N; Frydman-Marom A; Shalev DE; Segal D; Gazit E
PLoS One; 2010 Nov; 5(11):e13863. PubMed ID: 21085664
[TBL] [Abstract][Full Text] [Related]
10. Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants.
Xun Z; Kaufman TC; Clemmer DE
J Proteome Res; 2009 Oct; 8(10):4500-10. PubMed ID: 19705877
[TBL] [Abstract][Full Text] [Related]
11. Yeast red pigment modifies cloned human α-synuclein pathogenesis in Parkinson disease models in Saccharomyces cerevisiae and Drosophila melanogaster.
Nevzglyadova OV; Mikhailova EV; Artemov AV; Ozerova YE; Ivanova PA; Golomidov IM; Bolshakova OI; Zenin VV; Kostyleva EI; Soidla TR; Sarantseva SV
Neurochem Int; 2018 Nov; 120():172-181. PubMed ID: 30099122
[TBL] [Abstract][Full Text] [Related]
12. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
13. Roles of α-Synuclein and Disease-Associated Factors in
Suzuki M; Sango K; Nagai Y
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163450
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells.
Pennington K; Peng J; Hung CC; Banks RE; Robinson PA
J Proteome Res; 2010 May; 9(5):2390-401. PubMed ID: 20334438
[TBL] [Abstract][Full Text] [Related]
15. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.
Zhu ZJ; Wu KC; Yung WH; Qian ZM; Ke Y
Biochim Biophys Acta; 2016 Apr; 1862(4):518-525. PubMed ID: 26769358
[TBL] [Abstract][Full Text] [Related]
16. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
Haywood AF; Staveley BE
BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
[TBL] [Abstract][Full Text] [Related]
17. Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry.
Kellie JF; Higgs RE; Ryder JW; Major A; Beach TG; Adler CH; Merchant K; Knierman MD
Sci Rep; 2014 Jul; 4():5797. PubMed ID: 25052239
[TBL] [Abstract][Full Text] [Related]
18. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
20. Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic
Idowu OK; Oremosu AA; Dosumu OO; Mohammed AA
Fly (Austin); 2024 Dec; 18(1):2306687. PubMed ID: 38286464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
